We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+7.96%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.89B
AUM Growth
-$224M
Cap. Flow
-$320M
Cap. Flow %
-16.94%
Top 10 Hldgs %
41.2%
Holding
284
New
75
Increased
14
Reduced
41
Closed
116

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.53%
2 Healthcare 13.79%
3 Financials 12.96%
4 Communication Services 7.48%
5 Industrials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSLA icon
226
CALL
Tesla
TSLA
$1.26T
-75,000
Closed -$17.6M
TSLA icon
227
PUT
Tesla
TSLA
$1.26T
-630,000
Closed -$148M
TUSK icon
228
Mammoth Energy Services
TUSK
$142M
-65,166
Closed -$290K
TWI icon
229
Titan International
TWI
$465M
-74,329
Closed -$361K
UKOMW
230
DELISTED
Ucommune International Ltd Warrant
UKOMW
-50,000
Closed -$13K
VNT icon
231
Vontier
VNT
$4.97B
-248,716
Closed -$8.31M
VTR icon
232
CALL
Ventas
VTR
$47.3B
-150,000
Closed -$7.36M
VTR icon
233
PUT
Ventas
VTR
$47.3B
-150,000
Closed -$7.36M
VUZI icon
234
Vuzix
VUZI
$215M
-39,729
Closed -$361K
YARW
235
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
-1,658
Closed -$9.43M
WFC icon
236
Wells Fargo
WFC
$265B
-1,050,000
Closed -$31.7M
WRLD icon
237
World Acceptance Corp
WRLD
$886M
-18,400
Closed -$1.88M
XERS icon
238
Xeris Biopharma Holdings
XERS
$1.27B
-178,200
Closed -$877K
CMRX
239
DELISTED
Chimerix, Inc.
CMRX
-330,061
Closed -$1.59M
LUMO
240
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
-10,510
Closed -$375K
TFFP
241
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
-5,681
Closed -$2.03M
TCON
242
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
-3,750
Closed -$878K
ALPN
243
DELISTED
Alpine Immune Sciences Inc
ALPN
-23,493
Closed -$296K
CMLS
244
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
-41,645
Closed -$363K
FUV
245
DELISTED
Arcimoto, Inc. Common Stock
FUV
-1,225
Closed -$324K
MARK
246
DELISTED
Remark Holdings, Inc.
MARK
-13,603
Closed -$258K
ONCT
247
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
-36,445
Closed -$3.57M
SURF
248
DELISTED
Surface Oncology, Inc. Common Stock
SURF
-37,433
Closed -$346K
ACGN
249
DELISTED
Aceragen Inc
ACGN
-5,209
Closed -$325K
BWACU
250
DELISTED
Better World Acquisition Corp. Unit
BWACU
-300,000
Closed -$3.31M

Similar funds

683 Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, 683 Capital Management held 284 positions worth $1.89B, down 11% from $2.11B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

683 Capital Management withdrew a net $320M in Q1 2021, closing 116 positions and reducing 41 holdings. Its most notable exit was Capital One, an estimated $48.6M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

Against the trend, 683 Capital Management opened a new position in Herbalife worth $42.7M.

  • 683 Capital Management's largest Q1 2021 buy was Herbalife: 963,680 shares worth $42.7M.
  • 683 Capital Management added most to SmileDirectClub, Inc. Class A Common Stock in Q1 2021, an estimated $21.8M increase.
  • 683 Capital Management's biggest Q1 2021 reduction was Cardlytics, cutting an estimated $37M.
  • 683 Capital Management fully exited Capital One in Q1 2021, selling an estimated $48.6M.
  • 683 Capital Management's ten largest holdings make up 41% of its $1.89B portfolio in Q1 2021.
  • 683 Capital Management opened 75 new positions and closed 116 in Q1 2021.
  • 683 Capital Management's portfolio value fell 11% quarter-over-quarter to $1.89B.

Based on 683 Capital Management's 13F filing for Q1 2021, filed 17 May 2021.